MAIA Biotechnology, Inc.
MAIA
$1.27
-$0.03-2.31%
AMEX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -75.53% | 59.24% | -66.51% | -18.37% | -26.47% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -52.65% | 103.67% | -59.58% | 347.61% | 19.31% |
| Change in Net Operating Assets | 114.35% | -187.03% | 5,656.15% | -88.80% | 238.84% |
| Cash from Operations | 24.35% | -101.36% | 15.69% | 1.59% | -7.53% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 571.54% | 13.08% | 21.40% | -36.73% | 13.78% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1,580.71% | -1.37% | 33.69% | 13.73% | -52.53% |
| Cash from Financing | 546.60% | 13.40% | 24.25% | -37.59% | 12.71% |
| Foreign Exchange rate Adjustments | 190.38% | -1,460.00% | -111.90% | 170.97% | 111.57% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,253.02% | -398.94% | 203.95% | -156.96% | 38.61% |